Marsi-Bionics presents the clinical successes of its exoskeletons to internal medicine doctors

• The Atlas 2030, the world`s only exoskeleton for children, is capable of achieving much more effective therapy in the treatment of Spinal Muscular Atrophy
• The Mak Active Knee, the exoskeleton that works like a robotic knee, is achieving previously impossible rehabilitations due to speed and absence of pain

Elena Garcia Armada, founder of Marsi-Bionics and scientific researcher at the CSIC, has participated in the 41st Annual Congress of the Spanish Society of Internal Medicine. Within the eHealth area of the Congress, Dr. García Armada explained how engineering and artificial intelligence applied to robotics are revolutionizing the rehabilitation of neurological diseases.

Dr. García Armada has highlighted the importance of technological innovation when addressing rehabilitation after a stroke or Spinal Muscular Atrophy in the case of children. In both pathologies, physical rehabilitation constitutes vital work for patients that can affect their life expectancy. Currently, it is approached from a limited perspective regarding the use of technology, space, time and investment. These elements play against the effectiveness of the treatment and, therefore, against the well-being of the patients.

Faced with this situation, the clinical successes of the Marsi-Bionics exoskeletons have been exposed. The Atlas 2030, the only exoskeleton for children in the world, is capable of achieving a much deeper and more effective therapy in the treatment of Spinal Muscular Atrophy, managing to reduce the physical deterioration of patients.

The Mak Active Knee, the exoskeleton that works like a robotic knee, is already achieving previously impossible rehabilitations due to its speed, efficiency and absence of pain. At the moment, within the knee rehabilitation program of the BUPA Sanitas Group at the Hospital de La Zarzuela, but the clinical trial that addresses its use in patients who have suffered a stroke is already underway.

These two exoskeletons represent, today, two great exponents of how the use of technology at the service of health can achieve more clinical effectiveness, better patient care and savings in the use of resources.